Foghorn Total Assets from 2010 to 2024

FHTX Stock  USD 5.64  0.37  6.16%   
Foghorn TherapeuticsInc Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 280.8 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2010-12-31
Previous Quarter
285.9 M
Current Value
280.8 M
Quarterly Volatility
161.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Foghorn TherapeuticsInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Foghorn main balance sheet or income statement drivers, such as Net Interest Income of 11.1 M, Interest Income of 11.1 M or Depreciation And Amortization of 9.1 M, as well as many exotic indicators such as Price To Sales Ratio of 7.53, Dividend Yield of 0.0 or Days Sales Outstanding of 66.4 K. Foghorn financial statements analysis is a perfect complement when working with Foghorn TherapeuticsInc Valuation or Volatility modules.
  
This module can also supplement Foghorn TherapeuticsInc's financial leverage analysis and stock options assessment as well as various Foghorn TherapeuticsInc Technical models . Check out the analysis of Foghorn TherapeuticsInc Correlation against competitors.
For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn TherapeuticsInc guide.

Latest Foghorn TherapeuticsInc's Total Assets Growth Pattern

Below is the plot of the Total Assets of Foghorn TherapeuticsInc over the last few years. Total assets refers to the total amount of Foghorn TherapeuticsInc assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Foghorn TherapeuticsInc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Foghorn TherapeuticsInc's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Foghorn TherapeuticsInc's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 285.92 M10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

Foghorn Total Assets Regression Statistics

Arithmetic Mean143,787,886
Geometric Mean81,795,201
Coefficient Of Variation112.61
Mean Deviation137,068,647
Median43,058,000
Standard Deviation161,924,531
Sample Variance26219.6T
Range497.4M
R-Value0.73
Mean Square Error13056.3T
R-Squared0.54
Significance0
Slope26,547,921
Total Sum of Squares367073.8T

Foghorn Total Assets History

2024280.8 M
2023285.9 M
2022404.9 M
2021519.8 M
2020255.6 M
201922.3 M

Other Fundumenentals of Foghorn TherapeuticsInc

Foghorn TherapeuticsInc Total Assets component correlations

0.550.73-0.48-0.80.780.890.930.491.00.990.920.910.54-0.330.490.650.430.73
0.550.91-0.09-0.060.10.470.231.00.520.570.480.590.10.31-0.340.53-0.14-0.08
0.730.91-0.06-0.410.410.710.460.890.70.730.750.830.11-0.09-0.020.510.00.28
-0.48-0.09-0.060.41-0.45-0.36-0.55-0.05-0.48-0.48-0.38-0.33-0.99-0.06-0.110.02-0.88-0.37
-0.8-0.06-0.410.41-0.95-0.84-0.88-0.01-0.79-0.75-0.89-0.83-0.510.74-0.72-0.21-0.64-0.96
0.780.10.41-0.45-0.950.920.860.070.760.710.90.850.56-0.550.650.160.660.91
0.890.470.71-0.36-0.840.920.850.440.860.840.980.970.47-0.340.480.390.460.78
0.930.230.46-0.55-0.880.860.850.160.940.920.860.810.62-0.410.720.560.560.88
0.491.00.89-0.05-0.010.070.440.160.470.510.440.550.060.34-0.40.48-0.17-0.13
1.00.520.7-0.48-0.790.760.860.940.471.00.90.890.54-0.320.510.680.420.73
0.990.570.73-0.48-0.750.710.840.920.511.00.870.870.53-0.280.470.710.390.68
0.920.480.75-0.38-0.890.90.980.860.440.90.870.990.47-0.450.50.380.490.82
0.910.590.83-0.33-0.830.850.970.810.550.890.870.990.43-0.390.40.420.420.73
0.540.10.11-0.99-0.510.560.470.620.060.540.530.470.43-0.010.160.00.910.45
-0.330.31-0.09-0.060.74-0.55-0.34-0.410.34-0.32-0.28-0.45-0.39-0.01-0.590.09-0.32-0.68
0.49-0.34-0.02-0.11-0.720.650.480.72-0.40.510.470.50.40.16-0.590.330.270.87
0.650.530.510.02-0.210.160.390.560.480.680.710.380.420.00.090.33-0.280.22
0.43-0.140.0-0.88-0.640.660.460.56-0.170.420.390.490.420.91-0.320.27-0.280.58
0.73-0.080.28-0.37-0.960.910.780.88-0.130.730.680.820.730.45-0.680.870.220.58
Click cells to compare fundamentals

About Foghorn TherapeuticsInc Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Foghorn TherapeuticsInc income statement, its balance sheet, and the statement of cash flows. Foghorn TherapeuticsInc investors use historical funamental indicators, such as Foghorn TherapeuticsInc's Total Assets, to determine how well the company is positioned to perform in the future. Although Foghorn TherapeuticsInc investors may use each financial statement separately, they are all related. The changes in Foghorn TherapeuticsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Foghorn TherapeuticsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Foghorn TherapeuticsInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Foghorn TherapeuticsInc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Assets285.9 M280.8 M
Intangibles To Total Assets 0.00  0.00 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Foghorn TherapeuticsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Foghorn TherapeuticsInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Foghorn Therapeuticsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Foghorn Therapeuticsinc Stock:
Check out the analysis of Foghorn TherapeuticsInc Correlation against competitors.
For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn TherapeuticsInc guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Foghorn Stock analysis

When running Foghorn TherapeuticsInc's price analysis, check to measure Foghorn TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn TherapeuticsInc is operating at the current time. Most of Foghorn TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Foghorn TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn TherapeuticsInc's price. Additionally, you may evaluate how the addition of Foghorn TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Is Foghorn TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Foghorn TherapeuticsInc. If investors know Foghorn will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Foghorn TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.20)
Revenue Per Share
0.805
Quarterly Revenue Growth
(0.05)
Return On Assets
(0.20)
Return On Equity
(4.70)
The market value of Foghorn TherapeuticsInc is measured differently than its book value, which is the value of Foghorn that is recorded on the company's balance sheet. Investors also form their own opinion of Foghorn TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Foghorn TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Foghorn TherapeuticsInc's market value can be influenced by many factors that don't directly affect Foghorn TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Foghorn TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Foghorn TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Foghorn TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.